The absolute percent deviation of IGHV mutation rather than a 98% cut-off predicts survival of chronic lymphocytic leukaemia patients treated with fludarabine, cyclophosphamide and rituximab
Jain, Preetesh, Nogueras González, Graciela M., Kanagal-Shamanna, Rashmi, Rozovski, Uri, Sarwari, Nawid, Tam, Constantine, Wierda, William G., Thompson, Philip A., Jain, Nitin, Luthra, Rajyalakshmi, QLanguage:
english
Journal:
British Journal of Haematology
DOI:
10.1111/bjh.15018
Date:
November, 2017
File:
PDF, 472 KB
english, 2017